Social Media Influencers Driving Parallel Trade for Unlicensed Slimming Drug
A shadow economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Treatment Gaining Popularity Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are urged to contact these profiles directly for supplier links, while also obtaining discount codes.
Active Commerce on Social Networks
Additionally, a flourishing trade exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and assertions of rapid UK delivery. Sellers market the drug there before directing buyers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Healthcare Experts Express Worries
Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals administering products of uncertain source.
Some experts said the demand for the experimental drug could be connected to the increasing price of licensed weight loss products such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach medicines, advertising, and customer laws, potentially leading to fines, legal action or prison.
Platform Response and Material Removal
Based on TikTok, the service has removed violative material and prohibited related keywords and search suggestions. The company stated it was committed to keeping the platform secure and investing in strengthening enforcement strategies.
Online Trading Activities
Investigations also found groups with up to 9,000 members selling retatrutide using the platform's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up channels with numerous of users, filled with images of slimming results, positive testimonials and detailed guides for mixing or injecting at home.
After moments of joining one community, a seller posted WhatsApp details, where most purchases occur. The seller sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about weight, medical conditions or past usage.
Item Information and Costs
Within these groups, posts display black plastic packages with postal service stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20 milligrams. When asked how much time a injector should last, sellers give conflicting responses varying between a several days to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for the messaging service said it regularly monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering substances they can’t verify. Although the science behind retatrutide is valid, these digital versions may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.
Her team has already seen patients injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet authorized … may subject users to possibly serious medical dangers”.
